ALTEOGEN Market Cap

ALTEOGEN has a market cap or net worth of 19.95 trillion as of March 6, 2026. Its market cap has decreased by -4.39% in one year.

Market Cap

19.95T

Enterprise Value

19.70T

Revenue

202.18B

Ranking

n/a

PE Ratio

164.83

Stock Price

373,000.00

Market Cap Chart

Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 19.95T, an increase of 16,530.16%. That is a compound annual growth rate of 57.62%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	19.95T	-17.02%
Dec 30, 2025	24.04T	45.74%
Dec 30, 2024	16.49T	221.05%
Dec 28, 2023	5,137.84B	160.78%
Dec 29, 2022	1,970.17B	-38.41%
Dec 30, 2021	3,198.72B	-36.62%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Celltrion	46.29T
SK Biopharmaceuticals	8,348.19B
LigaChem Biosciences	6,916.97B
Peptron	6,074.17B
HLB Co., Ltd.	6,071.77B
Voronoi	5,693.87B
Samsung Biologics	76.24T
D&D Pharmatech	3,578.61B

Market Cap Rankings